Our study sought to assess long-term outcomes of percutaneously completed coronary revascularization (CCR) in patients with obstructive coronary artery disease (CAD) comprising chronic total occlusions (CTOs). Between 2010 and 2014, percutaneous coronary interventions (PCIs) of the CTOs were attempted in 213 patients: the CCR was achieved in 125 patients (group 1), while the PCI failed in 88 patients (group 2). They were matched against 252 patients (group 3) with the CCR obtained by the non-CTO PCIs. In the 5-year follow-up, more adverse cardiovascular (CV) events occurred in group 2 (29.5% vs 4.8% in group 1 vs 3.5% in group 3, P = .0001), mainly due to recurrent severe symptoms and additional revascularization of the CTOs; CV mortality did not seem to be significantly affected. Survival curves for the successful CTO and non-CTO PCIs appeared indistinguishable. Stent thromboses were infrequent in the CCR groups. In conclusion, long-term outcomes of the patients with the obstructive CAD containing the CTOs showed a favorable outcome if the CCR had been achieved percutaneously.
ManciniGHartiganPMBatesER. Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial. Am Heart J. 2013;166(3):481–7.
2.
ZimarinoMCalafioreAMDe CaterinaR. Complete myocardial revascularization: between myth and reality. Eur HeartJ. 2005;26(18):1824–30.
3.
BourassaMGYehWHolubkovRSopkoGDetreKM. Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA. A report from the NHLBI PTCA Registry. Eur Heart J. 1998;19(1):103–11.
4.
van der BrandMJRensingBJMorelMA. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol. 2002;39(4):559–64.
5.
HeadSJMackMJHolmesDR. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur J Cardiothorac Surg. 2012;41(3):535–41.
6.
HannanELRaczMHolmesDR. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006;113(20):2406–12.
7.
BellMRGershBJSchaffHV. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) registry. Circulation. 1992;86(2):446–57.
8.
RastanAJWaltherTFalkV. Does reasonable incomplete surgical revascularization affect early or long-term survival in patients with multivessel coronary artery disease receiving left internal mammary artery bypass to left anterior descending artery?Circulation. 2009;120(suppl 11):S70–7.
9.
SarnoGGargSOnumaY. Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study). Am J Cardiol. 2010;106(10):1369–75.
10.
GosslMFaxonDPBellMRHolmesDRGershBJ. Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease. Circ Cardiovasc Interv. 2012;5(4):597–604.
11.
FarooqVSerruysPWGarcia-GarciaHM. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions. the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. J Am Coll Cardiol. 2013;61(3):282–94.
12.
McLellanCSGhaliWALabinazM. Association between completeness of percutaneous coronary revascularization and postprocedure outcomes. Am Heart J. 2005;150(4):800–6.
13.
OngATLSerruysPW. Complete revascularization coronary artery bypass graft surgery versus percutaneous coronary intervention. Circulation. 2006;114(3):249–55.
14.
GalassiARTomaselloSDReifartN. In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. EuroIntervention. 2011;7(4):472–9.
15.
Di MarioCWernerGSSianosG. European perspective in the recanalisation of chronic total occlusions (CTO): consensus document from the EuroCTO Club. EuroIntervention. 2007;3(1):30–43.
16.
ValentiRMiglioriniASignoriniU. Impact of complete revascularization with percutaneous coronary intervention on survival in pts with at least one chronic total occlusion. Eur Heart J. 2008;29(19):2336–42.
17.
American Heart Association Grading Committee. Coronary artery disease reporting system. Circulation. 1975;51:31–3.
18.
SianosGMorelMAKappeteinAP. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219–27.
19.
WijnsWKolhPDanchinN. Guidelines on myocardial revascularization. Eur Heart J. 2010;31(20):2501–55.
20.
ThygesenKAlpertJSJaffeAS. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020–35.
21.
CutlipDEWindeckerSMehranR. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344–51.
22.
MehranRClaessenBEGodinoC. Long-term outcome of percutaneous coronary intervention for chronic total occlusions. JACC Cardiovasc Interv. 2011;4(9):952–61.
23.
StegPGBhattDLWilsonPW. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297(11):1197–206.
24.
CaliffRMArmstrongPWCarverJRD’AgostinoRBStraussWE. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol. 1996;27(5):1007–19.
25.
MaddoxTMStanislawskiMAGrunwaldGK. Nonobstructive CAD and risk of MI. JAMA. 2014;312(17):1754–63.
26.
AhmadiNNabaviVHajsadeghiF. Mortality incidence of patients with non-obstructive coronary artery disease diagnosed by computed tomography angiography. Am J Cardiol. 2011;107(1):10–6.
27.
van WerkumJWHeestermansAAZomerAC. Predictors of coronary stent thrombosis. J Am Coll Cardiol. 2009;53(16):1399–409.
28.
PatelVGBraytonKMTamayoA. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv. 2013;6(2):128–36.
29.
BrilakisESBanerjeeSKarmpaliotisD. Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol Intv. 2015;8(2):245–53.
30.
ColmenarezHJEscanedJFernandezC. Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(17):1854–66.
31.
KoDTChiuMGuoH. Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications. J Am Coll Cardiol. 2009;53(19):1773–82.
32.
SueroJAMarsoSPJonesPG. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol. 2001;38(2):409–14.
33.
BeharJMJonesDAWeerackodyR. Successful recanalisation of chronic total occlusions is associated with increased long term survival. BCS Abstracts. Heart. 2011;97(suppl 1):A25.
34.
SachdevaRAgrawalMFlynnSEWernerGSUretskyBF. The myocardium supplied by a chronic total occlusion is a persistently ischemic zone. Catheter Cardiovasc Interv. 2014;83(1):9–16.
35.
ClaessenBEvan der SchaafRJVeroudenNJ. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2009;2(11):1128–34.
36.
TajstraMPykaLGorolJ. Impact of chronic total occlusion of the coronary artery on long-term prognosis in patients with Ischemic systolic heart failure: insights from the COMMIT-HF registry. JACC Cardiovasc Interv. 2016;9(17):1790–7.
37.
van der SchaafRJVisMMSjauwKD. Impact of multi vessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion. Am J Cardiol. 2006;98(9):1165–9.
38.
KirschbaumSWBaksTvan den EntM. Evaluation of left ventricular function three years after percutaneous recanalization of chronic total coronary occlusions. Am J Cardiol. 2008;101(2):179–85.
39.
JoyalDAfilaloJRinfretS. Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. Am Heart J. 2010;160(1):179–87.
40.
KhanMFWendelCSThaiHMMovahedMR. Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: a meta-analysis comparing successful versus failed percutaneous intervention for chronic total occlusion. Catheter Cardiovasc Interv. 2013;82(1):95–107.
41.
ChristakopoulosGETararMNBrilakisES. The impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcomes. J Thorac Dis. 2015;7(7):1107–10.
42.
HannanELSamadashviliZWalfordG. Comparison of outcomes for patients receiving drug-eluting versus bare metal stents for non-ST-segment elevation myocardial infarction. Am J Cardiol. 2011;107(9):1311–8.
43.
BønaaKHMannsverkJWisethR. Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med. 2016;375(26):1242–52.
44.
RamunddalTHoebersLPHenriquesJP. Chronic total occlusions in Sweden—a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). PLoS One. 2014;9(8):e103850.
45.
Di MarioCSoriniC. Conquering CTO revascularisation: the summit is near with 90% of the ascent behind us. Euro Intervention. 2016;12(11):e1319–21.
